Search research articles
Contact Us
Filters
Showing results (631-640 of 680) with videos related to
Page
of 68
Sort By:
Radiology
|
May 27, 2010
Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort
Robert J Lewandowski, Mary F Mulcahy, Laura M Kulik, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 3, 2018
Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients ≥70 Years Old
Zhihong Wang, Chirag M Vyas, Olivia Van Benschoten, et al.
Radiology
|
November 24, 2005
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement
Mary C Frates, Carol B Benson, J William Charboneau, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 6, 2013
A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults
Anjuli Gupta, Samantha Ly, Luciana A Castroneves, et al.
Ultrasound Quarterly
|
December 6, 2006
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement
Mary C Frates, Carol B Benson, J William Charboneau, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 18, 2017
Differential Growth Rates of Benign vs. Malignant Thyroid Nodules
Trevor E Angell, Chirag M Vyas, Marco Medici, et al.
Hepatology (Baltimore, Md.)
|
December 2, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
Riad Salem, Ahmed Gabr, Ahsun Riaz, et al.
JAMA
|
June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial
Alan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Archives of Internal Medicine
|
May 30, 2007
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers
Charles L Bennett, Jonathan R Nebeker, Paul R Yarnold, et al.
Journal of the National Cancer Institute
|
December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology
Richard M Goldberg, Richard Adams, Marc Buyse, et al.
Page
of 68
Search research articles
Search
Showing results (631-640 of 680) with videos related to
Sort By:
Page
of 68
Radiology
|
May 27, 2010
Chemoembolization for hepatocellular carcinoma: comprehensive imaging and survival analysis in a 172-patient cohort
Robert J Lewandowski, Mary F Mulcahy, Laura M Kulik, et al.
Thyroid : Official Journal of the American Thyroid Association
|
April 3, 2018
Quantitative Analysis of the Benefits and Risk of Thyroid Nodule Evaluation in Patients ≥70 Years Old
Zhihong Wang, Chirag M Vyas, Olivia Van Benschoten, et al.
Radiology
|
November 24, 2005
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement
Mary C Frates, Carol B Benson, J William Charboneau, et al.
The Journal of Clinical Endocrinology and Metabolism
|
June 6, 2013
A standardized assessment of thyroid nodules in children confirms higher cancer prevalence than in adults
Anjuli Gupta, Samantha Ly, Luciana A Castroneves, et al.
Ultrasound Quarterly
|
December 6, 2006
Management of thyroid nodules detected at US: Society of Radiologists in Ultrasound consensus conference statement
Mary C Frates, Carol B Benson, J William Charboneau, et al.
The Journal of Clinical Endocrinology and Metabolism
|
October 18, 2017
Differential Growth Rates of Benign vs. Malignant Thyroid Nodules
Trevor E Angell, Chirag M Vyas, Marco Medici, et al.
Hepatology (Baltimore, Md.)
|
December 2, 2017
Institutional decision to adopt Y90 as primary treatment for hepatocellular carcinoma informed by a 1,000-patient 15-year experience
Riad Salem, Ahmed Gabr, Ahsun Riaz, et al.
JAMA
|
June 21, 2017
Effect of First-Line Chemotherapy Combined With Cetuximab or Bevacizumab on Overall Survival in Patients With KRAS Wild-Type Advanced or Metastatic Colorectal Cancer: A Randomized Clinical Trial
Alan P Venook, Donna Niedzwiecki, Heinz-Josef Lenz, et al.
Archives of Internal Medicine
|
May 30, 2007
Evaluation of serious adverse drug reactions: a proactive pharmacovigilance program (RADAR) vs safety activities conducted by the Food and Drug Administration and pharmaceutical manufacturers
Charles L Bennett, Jonathan R Nebeker, Paul R Yarnold, et al.
Journal of the National Cancer Institute
|
December 5, 2021
Clinical Trial Endpoints in Metastatic Cancer: Using Individual Participant Data to Inform Future Trials Methodology
Richard M Goldberg, Richard Adams, Marc Buyse, et al.
Page
of 68